I Diretriz Brasileira de Hipercolesterolemia Familiar (HF)

Pereira, AC; Gagliardi, ACM; Lottenberg, AM; Chacra, APM; Faludi, AA; Sposito, AC; Casella-Filho, A; Araújo, DB; Cesena, FHY; Ribeiro Filho, FF; Fonseca, FAH; Xavier, HT; Giuliano, I; Catani, LH; Bertolami, MC; Miname, MH; Izar, MC; Monte, O; Santos, RD; Maranhão, RC; Alves, RJ; Martinez, T; Machado, VA; Rocha, VZ; Salgado-Filho, W.
Arq. bras. cardiol ; 99(2,supl.2): 1-28, ago. 2012. ilus, tab
Artigo Português | LILACS | ID: lil-744284

Documentos relacionados

  1. Genetic Testing for Familial Hypercholesterolemia in Clinical Practice.
  2. The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia.
  3. Should Familial Hypercholesterolaemia Be Included in the UK Newborn Whole Genome Sequencing Programme?
  4. Stratification in Heterozygous Familial Hypercholesterolemia: Imaging, Biomarkers, and Genetic Testing.
  5. Barriers to and Facilitators of Implementing Guidelines for Detecting Familial Hypercholesterolaemia in Australia.
  6. Genetic and molecular architecture of familial hypercholesterolemia.
  7. How Can Implementation Science Improve the Care of Familial Hypercholesterolaemia?
  8. Application of motivational interviewing strategies with the extended parallel process model to improve risk communication for parents of children with familial hypercholesterolemia.
  9. Novel LDLR variants affecting low density lipoprotein metabolism identified in familial hypercholesterolemia.
  10. Aortic stenosis in homozygous familial hypercholesterolaemia: a paradigm shift over a century.